Related Experiment Videos
Protein-losing enteropathy in systemic lupus erythematosus.
T Tanaka1, A O Damião, A Gabriel Júnior
1Department of Rheumatology, University of São Paulo Medical School, Brazil.
Revista Do Hospital Das Clinicas
|January 1, 1991
Summary
Systemic lupus erythematosus can cause protein-losing enteropathy, a condition where the intestines lose protein. This case highlights that corticosteroid therapy can effectively treat this condition in lupus patients.
Area of Science:
- Gastroenterology
- Rheumatology
- Internal Medicine
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
- Protein-losing enteropathy (PLE) is a rare complication characterized by excessive protein loss through the gastrointestinal tract.
- Hypoalbuminemia without proteinuria or liver failure in SLE patients may indicate PLE.
Observation:
- A 23-year-old Brazilian woman with SLE presented with hypoalbuminemia and edema.
- Small intestinal biopsy revealed lymphangiectasia, consistent with PLE.
- The patient had no significant proteinuria or hepatic dysfunction.
Findings:
- The patient's protein-losing enteropathy showed a positive response to corticosteroid therapy.
- Lymphangiectasia was identified as the underlying cause of PLE in this SLE patient.
- Literature review suggests a potential link between SLE and intestinal lymphangiectasia.
Implications:
- Clinicians should consider PLE in SLE patients with unexplained hypoalbuminemia, especially in the absence of proteinuria or liver failure.
- Corticosteroid therapy may be a viable treatment option for PLE associated with SLE.
- Further research into the pathogenesis of SLE-related PLE is warranted.